Healthcare provider profile · identity verified

Joseph Yang, D.O.

Family Practice · COLORADO SPRINGS, CO · NPI 1750764411

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	708	210
Levothyroxine Sodium	Levothyroxine Sodium	547	155
Lisinopril	Lisinopril	442	130
Losartan Potassium	Losartan Potassium	438	133
Metformin Hcl	Metformin Hcl	405	123
Amlodipine Besylate	Amlodipine Besylate	376	114
Omeprazole	Omeprazole	339	102
Gabapentin	Gabapentin	294	75
Rosuvastatin Calcium	Rosuvastatin Calcium	202	63
Simvastatin	Simvastatin	201	59
Tamsulosin Hcl	Tamsulosin Hcl	193	64
Metoprolol Succinate	Metoprolol Succinate	180	57
Pantoprazole Sodium	Pantoprazole Sodium	154	49
Citalopram Hbr	Citalopram Hydrobromide	153	43
Trazodone Hcl	Trazodone Hcl	144	44
Hydrochlorothiazide	Hydrochlorothiazide	142	48
Albuterol Sulfate Hfa	Albuterol Sulfate	141	57
Alendronate Sodium	Alendronate Sodium	141	40
Tramadol Hcl	Tramadol Hcl	130	34
Jardiance	Empagliflozin	126	42
Zolpidem Tartrate	Zolpidem Tartrate	125	26
Allopurinol	Allopurinol	118	35
Eliquis	Apixaban	117	33
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	108	25
Lorazepam	Lorazepam	108	20
Pravastatin Sodium	Pravastatin Sodium	105	33
Furosemide	Furosemide	104	30
Potassium Chloride	Potassium Chloride	104	32
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	99	31
Fluticasone Propionate	Fluticasone Propionate	96	35
Donepezil Hcl	Donepezil Hcl	95	24
Famotidine	Famotidine	92	31
Escitalopram Oxalate	Escitalopram Oxalate	90	25
Metoprolol Tartrate	Metoprolol Tartrate	90	23
Bupropion Xl	Bupropion Hcl	89	29
Sertraline Hcl	Sertraline Hcl	82	27
Montelukast Sodium	Montelukast Sodium	80	25
Alprazolam	Alprazolam	77	22
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	76	16
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	75	23
Meloxicam	Meloxicam	75	23
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	74	22
Buspirone Hcl	Buspirone Hcl	69	21
Duloxetine Hcl	Duloxetine Hcl	67	19
Ozempic	Semaglutide	67	21
Carvedilol	Carvedilol	66	17
Trulicity	Dulaglutide	66	15
Ezetimibe	Ezetimibe	61	15
Glipizide Er	Glipizide	61	21
Quetiapine Fumarate	Quetiapine Fumarate	61	13
Fluoxetine Hcl	Fluoxetine Hcl	60	18
Ibandronate Sodium	Ibandronate Sodium	59	21
Xarelto	Rivaroxaban	58	13
Finasteride	Finasteride	54	20
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	53	13
Venlafaxine Hcl Er	Venlafaxine Hcl	52	15
Mirtazapine	Mirtazapine	50	19
Clonazepam	Clonazepam	47	suppressed
Fenofibrate	Fenofibrate	47	16
Spironolactone	Spironolactone	46	15
Promethazine Hcl	Promethazine Hcl	45	suppressed
Atenolol	Atenolol	44	13
Metformin Hcl Er	Metformin Hcl	44	16
Lovastatin	Lovastatin	43	13
Ibuprofen	Ibuprofen	41	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	40	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	40	23
Pregabalin	Pregabalin	39	12
Glipizide	Glipizide	38	13
Lidocaine	Lidocaine	38	22
Diclofenac Sodium	Diclofenac Sodium	37	18
Mounjaro	Tirzepatide	37	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	35	13
Prolia	Denosumab	35	20
Spiriva Respimat	Tiotropium Bromide	35	11
Tizanidine Hcl	Tizanidine Hcl	35	suppressed
Warfarin Sodium	Warfarin Sodium	35	suppressed
Januvia	Sitagliptin Phosphate	32	suppressed
Synthroid	Levothyroxine Sodium	32	suppressed
Farxiga	Dapagliflozin Propanediol	31	suppressed
Belsomra	Suvorexant	30	suppressed
Estradiol	Estradiol	30	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	29	suppressed
Methocarbamol	Methocarbamol	28	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	28	18
Ventolin Hfa	Albuterol Sulfate	28	14
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	27	suppressed
Doxepin Hcl	Doxepin Hcl	27	suppressed
Myrbetriq	Mirabegron	27	suppressed
Novolog Flexpen	Insulin Aspart	27	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	27	suppressed
Clotrimazole	Clotrimazole	26	suppressed
Eszopiclone	Eszopiclone	26	suppressed
Olanzapine	Olanzapine	26	suppressed
Prednisone	Prednisone	26	16
Benazepril Hcl	Benazepril Hcl	25	suppressed
Chlorthalidone	Chlorthalidone	25	suppressed
Lamotrigine	Lamotrigine	25	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	25	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	25	suppressed
Telmisartan	Telmisartan	25	suppressed
Carbamazepine	Carbamazepine	24	suppressed
Clopidogrel	Clopidogrel Bisulfate	24	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	24	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	23	suppressed
Glimepiride	Glimepiride	23	suppressed
Propranolol Hcl	Propranolol Hcl	23	suppressed
Acyclovir	Acyclovir	22	suppressed
Breo Ellipta	Fluticasone/Vilanterol	22	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	22	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	21	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	21	suppressed
Valacyclovir	Valacyclovir Hcl	21	14
Ondansetron Hcl	Ondansetron Hcl	20	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	20	suppressed
Valsartan	Valsartan	20	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	19	suppressed
Ondansetron Odt	Ondansetron	19	11
Paroxetine Hcl	Paroxetine Hcl	19	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	19	17
Verapamil Er	Verapamil Hcl	19	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	18	suppressed
Ipratropium Bromide	Ipratropium Bromide	18	suppressed
Azelastine Hcl	Azelastine Hcl	17	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	16	suppressed
Sildenafil Citrate	Sildenafil Citrate	16	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	16	suppressed
Celecoxib	Celecoxib	15	11
Methylphenidate Hcl	Methylphenidate Hcl	15	suppressed
Oxycodone Hcl	Oxycodone Hcl	15	suppressed
Tresiba Flextouch U-100	Insulin Degludec	15	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	14	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	14	13
Carbidopa-Levodopa	Carbidopa/Levodopa	14	suppressed
Cholestyramine	Cholestyramine (With Sugar)	14	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	14	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	14	suppressed
Atomoxetine Hcl	Atomoxetine Hcl	13	suppressed
Cefuroxime	Cefuroxime Axetil	13	12
Doxycycline Hyclate	Doxycycline Hyclate	13	suppressed
Fyavolv	Norethindrone Ac/Eth Estradiol	13	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Repatha Syringe	Evolocumab	13	suppressed
Topiramate	Topiramate	13	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	12	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Azithromycin	Azithromycin	12	12
Calcitonin-Salmon	Calcitonin,salmon,synthetic	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Ropinirole Hcl	Ropinirole Hcl	12	suppressed
Temazepam	Temazepam	12	suppressed
Tradjenta	Linagliptin	12	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	11	suppressed
Gemtesa	Vibegron	11	suppressed
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Levemir Flexpen	Insulin Detemir	11	suppressed
Spiriva Handihaler	Tiotropium Bromide	11	suppressed
Varenicline Tartrate	Varenicline Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error